Hormonal Contraceptives Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Product (Oral Contraceptives, Skin Patches, Intrauterine Devices, Hormonal Implants, Others), By Hormone, By Distribution Channel and Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 3.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Primary driving factors for the growth of hormonal contraceptives market are increasing focus on family planning among the people and continuous support from the government. Furthermore, advancements in hormonal contraception such as the advent of hormonal patches, implants and other innovative drug-device combination products are fuelling the market growth. Moreover, the need for preventing unintended pregnancy, urbanization coupled with user awareness is projected to boost the market growth over the forecast period. According to the World Health Organization (WHO), about 74 million women in low and middle-income countries have unintended pregnancies annually, leading to 25 million unsafe abortions and 47000 maternal deaths.

In addition, companies efforts in producing the innovative hormonal contraceptives with fewer side effects and enhanced efficiency anticipated boosting the usage of hormonal contraceptives in the near future. However, side effects associated with the usage of hormonal contraceptives and availability hormone-free contraceptives may hamper the market growth.

Scope of the Report

Hormonal contraceptives are one of the birth control methods that act on the endocrine system. This includes the use of hormones such as progesterone and estrogen to prevent pregnancy by preventing ovulation. The report covers contraceptives which include hormone, prevents ovulation and pregnancy and maybe pharmaceutical or medical device.

By Product
Oral Contraceptives
Skin Patches
Intrauterine Devices
Hormonal Implants
By Hormone
Progestin Only
Combined Hormone Contraceptives
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Contraceptive Pills Expected to Have Significant Share

In the product segment, contraceptive hormonal pills are expected to have significant share owing to ease of use and availability. Moreover, the availability of pipeline products and their expected commercialization anticipated to boost the segment growth furthermore. Combination hormonal contraceptives are anticipated to have a notable market share due to their better efficiency and success rate in preventing pregnancy. In addition, companies focus on new product launches and advancing the combination hormonal contraceptives may bolster the segment growth. Intrauterine devices anticipated to have notable growth rate due to adaptation of long-acting contraception devices couple with efficiency.

Moreover, the increasing research and development investments and product pipelines in hormonal contraception and new product launch expected to boost the overall market growth.

Hormonal Contraceptin Trends

North America Expected to have Significant Market Share

Owing to the high adoption of hormonal contraceptives, well-established healthcare infrastructure and presence of key market players in the region, North America hormonal contraceptives market is expected to grow at significant rates. According to the Center for Disease Control and Prevention (CDC), in 2015-2017, 72.2 million US woman aged between 19-49 were using contraceptives. In addition, government initiatives in increasing awareness regarding birth control and growing affordability fueling the market growth.

The developed countries in Europe such as United Kingdom and Germany are having well-established healthcare infrastructure and high awareness regarding hormonal contraception which is expected to boost regional growth. The Asia-Pacific region is projected to have considerable growth rate owing to developing healthcare infrastructure and availability of a large pool of population using contraception.

Hormonal Contraceptives Market -  Growth Rate by Region - Image

Competitive Landscape

Global hormonal contraceptives market is moderately fragmented and competitive. Market players are focusing on product innovations, new product launches and regional expansions to increase their market share. The key market players operating in clot management devices market include Allergan plc, Afaxys, Inc., Merck & Co., Inc., Pfizer, and Mylan N.V. among others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Focus on Family Planning and Favorable Regulations by Government

      2. 4.2.2 Advancements in Hormonal Contraception

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of Alternative Contraceptive Methods

      2. 4.3.2 Health Risks Associated With Hormonal Contraception

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Oral Contraceptives

      2. 5.1.2 Skin Patches

      3. 5.1.3 Intrauterine Devices

      4. 5.1.4 Hormonal Implants

      5. 5.1.5 Others

    2. 5.2 By Hormone

      1. 5.2.1 Progestin Only

      2. 5.2.2 Combined Hormone Contraceptives

    3. 5.3 By Distribution Channel

      1. 5.3.1 Hospital Pharmacies

      2. 5.3.2 Retail Pharmacies

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Allergan plc

      2. 6.1.2 Afaxys, Inc.

      3. 6.1.3 Merck & Co., Inc.

      4. 6.1.4 Pfizer Inc.

      5. 6.1.5 Mylan N.v.

      6. 6.1.6 Bayer AG

      7. 6.1.7 Agile Therapeutics

      8. 6.1.8 Novartis AG

      9. 6.1.9 Johnson & Johnson

      10. 6.1.10 The Piramal Group

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Hormonal Contraceptives Market market is studied from 2018 - 2026.

The Hormonal Contraceptives Market is growing at a CAGR of 3.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Allergan plc, Afaxys, Inc., Merck & Co., Inc., Pfizer Inc., Mylan N.V. are the major companies operating in Hormonal Contraceptives Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!